For research use only. Not for therapeutic Use.
FFENM(CAT: I027445) is a novel and potent neuroprotective agent, gaining attention for its potential in the treatment of Alzheimer’s disease. It exhibits unique properties that target key mechanisms underlying neurodegeneration, such as oxidative stress, inflammation, and synaptic dysfunction. By mitigating neuronal damage and preserving cognitive function, FFENM provides a promising avenue for preclinical research into Alzheimer’s therapy. Its innovative mechanism of action positions it as a valuable tool for exploring novel therapeutic strategies aimed at addressing the progression of neurodegenerative disorders, particularly Alzheimer’s disease.
Catalog Number | I027445 |
CAS Number | 1639210-26-6 |
Synonyms | FFENM; Fluoroethylnormemantine; |
Molecular Formula | C12H20FN |
Purity | 98% |
Target | Neuronal Signaling |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (5S,7R)-3-(2-fluoroethyl)adamantan-1-amine |
InChI | InChI=1S/C12H20FN/c13-2-1-11-4-9-3-10(5-11)7-12(14,6-9)8-11/h9-10H,1-8,14H2/t9-,10+,11?,12? |
InChIKey | HUYVZSFADWYSHD-ZYANWLCNSA-N |
SMILES | C1[C@@H]2CC3(C[C@H]1CC(C2)(C3)N)CCF |